Lumida
/UTMD
⌘K
Utah Medical Products Inc

Utah Medical Products Inc

UTMD
$69.71USD+0.10%+0.07 today

MARKET CAP

221.9M

P/E (TTM)

20.6x

FWD P/E

DAY RANGE

$69 – $70

52W RANGE

$54
$76

AI Summary

Stalk
Sell NowHigh

UTMD’s price has dipped below the 9EMA, 20EMA, and 50DMA with an active Lower Highs & Lower Lows pattern indicating supply dominance and downward momentum. In a Stage 4 decline with neutral OB/OS, the medium-term posture remains bearish. Short-term timing conditions align with further downside as price tightly tracks below sloping EMAs. Execution is now appropriate on rallies into the broken EMA cluster. Only a sustained reclaim above these EMAs and recent resistance zone would invalidate this stance.

  • Earnings Yield 36.7% and Dividend Yield 1.8% support income investors.
  • Q2 revenue fell 14.3% to $8.53M while gross margin stayed 55.8%.
  • 2026 sales forecast cut 10–13% after customer losses
Full analysis →
Insider Trades3 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
May 28, 2026SellUTMDBrian KoopmanPrincipal Financial Officer50$66.27$221.9M-7.97%+29.91%$3.3K-6.01%Stalk
Sep 4, 2025SellUTMDBrian KoopmanPrincipal Financial Officer50$62.75$221.9M-7.97%+29.91%$3.1K-5.67%Stalk
Jul 18, 2024SellUTMDBrian KoopmanPrincipal Financial Officer50$71.61$221.9M-7.97%+29.91%$3.6K-5.36%Stalk